After the birth of the new national-defined amino acid, Harrison Clark, although not needing it himself, was the first to volunteer as a clinical trial participant.
Compared to the original version, which could focus attention but reduce emotional activity proportionally, the new type of national-defined amino acid had no side effects and only further stimulated human inspiration.
The difference between the two was like night and day.
In 2060, after a continuous forty-year period of high-intensity technological explosion, the fundamental sciences finally met the required standards.
As Harrison Clark's Mars Development Fleet, with an investment of trillions, was officially launched, the first batch of genetic awakening test instruments came online almost simultaneously.
